Ads
related to: tecfidera costmigrainetreatmentinformation.com has been visited by 100K+ users in the past month
- Savings and Support
Find savings and support info for
a treatment for migraine.
- How Treatment Works
Gain a deeper understanding of
how treatment works.
- Review FAQs
Review frequently asked questions
about a migraine treatment.
- Treatment Locator
Discover a convenient location
for you to receive treatment.
- Treatment May Help
Visit the patient website for info
on a migraine treatment.
- Sign Up for Information
Sign up for information on a
migraine treatment option.
- Savings and Support
Search results
Biogen holds onto Tecfidera market in Europe for a little longer
BioPharma Dive via Yahoo Finance· 5 months agoA decision by European regulators to revoke approvals for five generic versions of Biogen's multiple...
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have lost about...
Biogen (BIIB) Q4 Earnings & Sales Miss Estimates, Stock Falls
Zacks via Yahoo Finance· 3 months agoBiogen BIIB reported fourth-quarter 2023 adjusted earnings per share (EPS) of $2.95, which missed...
Why Is Biogen Inc. (BIIB) Up 6.4% Since Last Earnings Report?
Zacks via Yahoo Finance· 5 months agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
Biogen (BIIB) Beats on Q2 Earnings & Sales, Ups 2022 Guidance
Zacks via Yahoo Finance· 2 years agoBiogen BIIB reported second-quarter 2022 earnings per share (EPS) of $5.25, which significantly beat...
Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business Daily· 3 months agoBiogen's turnaround is still a "work in progress," an analyst said Tuesday as Biogen stock slumped...
Biogen tops 3Q expectations as cost cutting continues
Associated Press via Yahoo News· 2 years agoBiogen delivered a better-than-expected third quarter and hiked its 2022 forecast, as cost cutting...
Biogen (BIIB) Beats on Q1 Earnings, Ends Some Research Programs
Zacks via Yahoo Finance· 1 year agoBiogen BIIB reported first-quarter 2023 adjusted earnings per share (EPS) of $3.40, beating the...
Biogen fourth-quarter profit misses on Aduhelm exit costs
Reuters via AOL· 3 months agoLast month, Biogen said it will end a post-approval study of Aduhelm and return the licensing rights...
Biogen CEO bets on Alzheimer's drug, pipeline to return to growth
Reuters via Yahoo Finance· 1 year ago(Reuters) -Biogen Inc Chief Executive Officer Christopher Viehbacher said on Wednesday he is banking...
